Patents by Inventor Michael Schwarm

Michael Schwarm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240180978
    Abstract: The current invention concerns preparations comprising probiotic strains belonging to the genus Lactobacillus in combination with the amino acid L-tryptophan.
    Type: Application
    Filed: February 28, 2022
    Publication date: June 6, 2024
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Michael SCHILLING
  • Publication number: 20240156882
    Abstract: The current invention concerns preparations comprising at least one probiotic strain belonging to the species Lactobacillus helveticus, Lactobacillus rhamnosus (Lacticaseibacillus rhamnosus), Lactobacillus mucosae (Limosilactobacillus mucosae), and Lactobacillus johnsonii and anthocyanins.
    Type: Application
    Filed: February 28, 2022
    Publication date: May 16, 2024
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Heike TOM DIECK, Michael SCHILLING, Michael SCHWARM, Bodo SPECKMANN
  • Patent number: 11805798
    Abstract: A solid product composition includes at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid. The solid product composition is formed by (i) providing a starting composition containing at least one polyunsaturated omega-3 fatty acid component; (ii) providing a lysine composition; and (iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting resulting admixture to spray drying conditions subsequently, thus forming the solid product composition containing at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: November 7, 2023
    Assignee: Evonik Operations GmbH
    Inventors: Günter Knaup, Milan Latinovic, Michael Schwarm
  • Publication number: 20230149336
    Abstract: A composition for use as antioxidant, where the composition has at least one polyunsaturated fatty acid component and at least one anthocyanin component. The polyunsaturated fatty acid component is an amino acid salt of the omega-3 fatty acids eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). The anthocyanin component is cyanidin-3-glucoside, delphinidin-3-glucoside, malvidin-3-galactoside, peonidin-3-galactoside, or malvidin-3-glucoside. A method for treating a disease with the composition. A method of providing an antioxidant to a subject with the composition.
    Type: Application
    Filed: March 24, 2021
    Publication date: May 18, 2023
    Applicant: Evonik Operations GmbH
    Inventors: Rosario LIZIO, Michael SCHWARM, Albino CARRIZZO, Carmine VECCHIONE
  • Publication number: 20230128187
    Abstract: A preparation comprising probiotic strains belonging to the genera Bacillus sp., Lactobacillus sp., optionally Pediococcus sp. as viable cells or cytoplasmic extract thereof, and proteases, wherein the strains can degrade peptide sequences of gliadins. The preparation can be used to produce gluten-free foods from gluten-containing cereals or to treat gluten-related disorders.
    Type: Application
    Filed: November 27, 2020
    Publication date: April 27, 2023
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Stefan PELZER, Thomas BERNGRUBER, Marco GOBBETTI, Raffaella DI CAGNO
  • Patent number: 11622952
    Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salts, a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: April 11, 2023
    Assignee: Evonik Operations GmbH
    Inventors: Thomas Gottstein, Michael Schwarm, Guenter Knaup
  • Publication number: 20230056888
    Abstract: A composition may be used in vascular relaxation, wherein the composition may include one or more anthocyanins.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Applicant: Evonik Operations GmbH
    Inventors: Rosario LIZIO, Michael SCHWARM, Albino CARRIZZO, Carmine VECCHIONE
  • Publication number: 20230042485
    Abstract: This invention concerns a process to identify consortia of probiotic strains belonging to e.g. the genera Lactobacillus, Bacillus, Pediococcus, and Weissella that can be used in preparations for food supplement, food production, and pharmaceutical applications with the intention to execute a safe and rapid degradation of gluten to non-toxic, non-immunogenic digests.
    Type: Application
    Filed: November 27, 2020
    Publication date: February 9, 2023
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Stefan PELZER, Thomas BERNGRUBER, Marco GOBBETTI, Raffaella DI CAGNO
  • Publication number: 20220312816
    Abstract: The invention discloses preparations for use in enhancing formation of short-chain fatty acids (SCFAs) in a subject for treating or preventing a disease or disorder comprising at least one omega-3 fatty acid salt having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, wherein the omega-3 fatty acid is selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and a colon-specific delivery system.
    Type: Application
    Filed: May 18, 2020
    Publication date: October 6, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Ines OCHROMBEL, Stefan PELZER
  • Publication number: 20220265749
    Abstract: Preparations may include at least one extract of gum resins from Boswellia species and at least one omega-3 fatty acid salt selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Surprisingly, such combinations of extracts of gum resins from Boswellia species and polyunsaturated fatty acid salt can cause a marked and unexpected increase in the biosynthesis of specialized pro-resolving mediators (SPM) in a synergistic manner, proposing benefit for resolution of inflammatory conditions.
    Type: Application
    Filed: July 30, 2020
    Publication date: August 25, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Mario GOMEZ, Bodo SPECKMANN, Michael SCHWARM, Oliver WERZ
  • Publication number: 20220267719
    Abstract: The invention relates to method for loading microorganisms or parts thereof on and/or in pre-synthesized multiphase biomaterials comprising nanocellulose wherein the microorganisms are resuspended in a buffer or a culture medium and loaded into and/or onto the multiphase biomaterial and the use of such a loaded multiphase biomaterial in nutritional, food, pharmaceutical, medical, cosmetic, especially oral, mucosal, dermal and transdermal, ocular, dermatological or female health applications.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 25, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Jürgen Erwin LANG, Heike TOM DIECK, Michael SCHWARM, Bassam AL MESLMANI, Dagmar FISCHER
  • Publication number: 20220088091
    Abstract: A synbiotic preparation may include at least one probiotic strain and at least one amino acid or derivative thereof selected from glutamine, glutamic acid or salts thereof, conjugated glutamine, or oligopeptides of 2-10 amino acid units in length, wherein the amino acid units may be natural amino acids, and at least one amino acid unit being a glutamine or glutamic acid unit.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 24, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Ines OCHROMBEL, Bodo SPECKMANN, Stefan PELZER, Michael SCHWARM, Walter PFEFFERLE
  • Patent number: 11219235
    Abstract: The present invention relates to a method for preparing a composition comprising one or more omega-3 fatty acid salt(s), the composition obtainable or obtained by this method, and also the use of this composition for the preparation of foodstuffs, food supplements or pharmaceutical products.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: January 11, 2022
    Assignee: Evonik Operations GmbH
    Inventors: Guenter Knaup, Milan Latinovic, Joerg Lotz, Michael Schwarm
  • Publication number: 20210393565
    Abstract: The invention relates to preparation comprising at least one omega-3 or omega-6 fatty acid component selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, or arachidonic acid (ARA) and/or derivatives thereof for use to increase the formation of one or more specialized pro-resolving lipid mediators (SPM) by gastrointestinal microorganisms in the gastrointestinal tract of humans or animals wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt.
    Type: Application
    Filed: November 28, 2019
    Publication date: December 23, 2021
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Ines OCHROMBEL, Martin SCHILLING, Mario GOMEZ, Michael SCHWARM, Stefan PELZER, Jessica KLEINBÖLTING, Thomas BERNGRUBER
  • Publication number: 20210392935
    Abstract: The invention relates to preparation comprising at least one probiotic strain belonging to the genus Bacillus megaterium, and a polyunsaturated fatty acid component comprising at least one omega-3 or omega-6 fatty acid selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt. The invention further relates to use of the inventive preparation as a feed or food supplement, pharmaceutical product, feed-or foodstuff compositions and for topical applications.
    Type: Application
    Filed: November 28, 2019
    Publication date: December 23, 2021
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Ines OCHROMBEL, Martin SCHILLING, Mario GOMEZ, Michael SCHWARM, Stefan PELZER, Jessica KLEINBÖLTING, Thomas BERNGRUBER
  • Publication number: 20210121429
    Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salts, a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.
    Type: Application
    Filed: August 15, 2018
    Publication date: April 29, 2021
    Applicant: Evonik Operations GmbH
    Inventors: Thomas GOTTSTEIN, Michael SCHWARM, Guenter KNAUP
  • Publication number: 20200375235
    Abstract: A solid product composition includes at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid. The solid product composition is formed by (i) providing a starting composition containing at least one polyunsaturated omega-3 fatty acid component; (ii) providing a lysine composition; and (iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting resulting admixture to spray drying conditions subsequently, thus forming the solid product composition containing at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid.
    Type: Application
    Filed: August 18, 2020
    Publication date: December 3, 2020
    Applicant: Evonik Operations GmbH
    Inventors: Günter KNAUP, Milan Latinovic, Michael Schwarm
  • Patent number: 10798962
    Abstract: A process for increasing the stability of a composition containing a polyunsaturated omega-3 fatty acid against oxidation proceeds by (i) providing a starting composition containing at least one polyunsaturated omega-3 fatty acid component; (ii) providing a lysine composition; (iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting resulting admixture to spray drying conditions subsequently, thus forming a solid product composition containing at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid; the product composition exhibiting a solvent content SC selected from the following: SC<5 wt %, SC<3 wt %, SC<1 wt %, or SC<0.5 wt %.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: October 13, 2020
    Assignee: Evonik Operations GmbH
    Inventors: Günter Knaup, Milan Latinovic, Michael Schwarm
  • Publication number: 20200315970
    Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salt(s), a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.
    Type: Application
    Filed: May 24, 2017
    Publication date: October 8, 2020
    Applicant: Evonik Technochemie GmbH
    Inventors: Thomas GOTTSTEIN, Guenter KNAUP, Michael SCHWARM
  • Publication number: 20200315230
    Abstract: The present invention relates to a method for preparing a composition comprising one or more omega-3 fatty acid salt(s), the composition obtainable or obtained by this method, and also the use of this composition for the preparation of foodstuffs, food supplements or pharmaceutical products.
    Type: Application
    Filed: May 24, 2017
    Publication date: October 8, 2020
    Applicant: EVONIK TECHNOCHEMIE GMBH
    Inventors: Guenter KNAUP, Milan LATINOVIC, Jörg LOTZ, Michael SCHWARM